Software company, Veeva Systems, is planning to undertake an initial public offer of its shares. The company is scheduling it for the third quarter of 2013, with a selection of banks already discussing the terms of the deal.
The company which focuses its software on life science topics is based out of Pleasanton, CA has engaged the services of Morgan Stanley and Deutsche Bank AG to lead the sale. This was confirmed by anonymous sources familiar with the matter.
When sought for comment on the transaction, Deutsche Bank and Morgan Stanley declined to make any comment. This was the same tact applied by Veeva Systems when sought for comments.
Veeva offers to the market web-based software for pharmaceutical sales forces to allow them the ability to track drug information as well as provide both data and documentation to their individual sales persons. It also has built a content management system for drug companies to manage information on drug development that would help maintain compliance requirements and also facilitate the approval processes.
Join the Conversation